As a type of tyrosine kinase inhibitor, Tarceva® (erlotinib) is a medication that blocks certain proteins in the body in order to fight cancer. Specifically, Tarceva is indicated in advanced cases of the following conditions:
When used for non-small cell lung cancer, it may be used on its own. However, when prescribed for pancreatic cancer, Tarceva is used in combination with another medication known as gemcitabine (Gemzar®). Tarceva is currently approved for use in adults only.
(Click Tarceva Uses for a more in-depth look at what this medication is used for, as well as how it works and why it may need to be used with extra caution in certain age groups.)
HealthSavvy Sign In
|